perfusion and structure during procedures. The company’s technology uses non-contact, non-invasive optical imaging based on light alone, eliminating the need for external contrast agents while enabling tissue differentiation between tumors, healthy tissue, nerves, and blood vessels. Its systems are designed to integrate into surgical workflows and provide objective data to complement surgeons’ visual assessments, which are often subjective. The company continues to advance and evaluate its imaging platform through clinical studies aimed at improving surgical precision and patient outcomes across multiple specialties.